|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
1999-4-13
|
|
pubmed:abstractText |
Mycophenolate mofetil (MMF) has been shown to have promise in short-term liver transplantation graft rescue studies. The purpose of this study was to evaluate the long-term efficacy and safety of MMF in liver transplant patients who had failed cyclosporine (CsA)-based conventional immunosuppression.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0041-1337
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
67
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
707-12
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:10096526-Adult,
pubmed-meshheading:10096526-Cytomegalovirus Infections,
pubmed-meshheading:10096526-Female,
pubmed-meshheading:10096526-Follow-Up Studies,
pubmed-meshheading:10096526-Gastrointestinal Diseases,
pubmed-meshheading:10096526-Graft vs Host Disease,
pubmed-meshheading:10096526-Humans,
pubmed-meshheading:10096526-Immunosuppressive Agents,
pubmed-meshheading:10096526-Liver Transplantation,
pubmed-meshheading:10096526-Male,
pubmed-meshheading:10096526-Middle Aged,
pubmed-meshheading:10096526-Mycophenolic Acid,
pubmed-meshheading:10096526-Neoplasms,
pubmed-meshheading:10096526-Treatment Outcome
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
Four-year follow-up of mycophenolate mofetil for graft rescue in liver allograft recipients.
|
|
pubmed:affiliation |
Department of Pharmacy, University of Washington, Seattle 98195-7630, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
